This paper examines the health consequences of the rapid increase in antidepressant consumption in Switzerland (2002–2014). Using a shift-share instrumental variable approach, we exploit regional variation in sales driven by product innovation (the shift) and the market power of pharmaceutical firms (the share). Our findings reveal that a one defined daily dose per 1,000 inhabitants increase in antidepressant sales raises hospital admissions for adverse drug reactions by 18% and for depression by 6%. Financial incentives for self-dispensing doctors and reduced access to psychotherapy emerge as key drivers, highlighting concerns about overtreatment and suboptimal prescribing practices.
(2026). Happy Pills? The Health Consequences of the Dramatic Increase in Antidepressant Use [journal article - articolo]. In ECONOMIC JOURNAL. Retrieved from https://hdl.handle.net/10446/339765
Happy Pills? The Health Consequences of the Dramatic Increase in Antidepressant Use
Masiero, Giuliano;Mazzonna, Fabrizio;
2026-11-11
Abstract
This paper examines the health consequences of the rapid increase in antidepressant consumption in Switzerland (2002–2014). Using a shift-share instrumental variable approach, we exploit regional variation in sales driven by product innovation (the shift) and the market power of pharmaceutical firms (the share). Our findings reveal that a one defined daily dose per 1,000 inhabitants increase in antidepressant sales raises hospital admissions for adverse drug reactions by 18% and for depression by 6%. Financial incentives for self-dispensing doctors and reduced access to psychotherapy emerge as key drivers, highlighting concerns about overtreatment and suboptimal prescribing practices.Pubblicazioni consigliate
Aisberg ©2008 Servizi bibliotecari, Università degli studi di Bergamo | Terms of use/Condizioni di utilizzo

